It’s estimated that as many as 8,000 predatory journals—which eschew scientific integrity in favor of profits—now exist and that they “publish” a total of more than 400,000 items annually. Conventional wisdom says that researcher-authors who become prey for these journals reside predominantly in the developing world. However, a recent commentary in Nature summarizing findings from an analysis of nearly 2,000 biomedical articles in more than 200 journals thought to be predatory, found that 57% of the corresponding authors hailed from high- and upper-middle-income countries. In fact, corresponding authors in the US—including some from Harvard University, the University of Texas, and the Mayo Clinic—produced more articles in this sample than any other country except India.
We have heard anecdotal reports of relatively experienced US authors being duped into submitting to predatory journals, only to find that, once aware of the situation, they had no recourse by which to withdraw or extract their work.
“In our view, publishing in predatory journals is unethical,” the Nature commentators say, emphasizing that everyone in the research chain—authors, publishers, institutions, and funders—has a responsibility to prevent research from appearing in such journals. The controversial online list of journals and publishers that were potentially, probably, or possibly predatory compiled by university librarian Jeffrey Beall was taken down earlier this year, but according to the commentary, authors can still spot potentially predatory journals by looking out for the following characteristics:
- Article processing fees < $150
- Spelling and grammatical errors on the journal’s website
- Overly broad scope
- Language that targets authors more than readers
- Promises of rapid publication
- Submission of manuscripts via email
For their part, say the commentators, research institutions and funders should train researchers in sound journal-selection practices and carefully audit where grantees and faculty are published by checking journal titles against the Directory of Open Access Journals (DOAJ).
Jason Miller, JBJS Executive Publisher
Lloyd Resnick, JBJS Developmental Editor
The National Library of Medicine has accepted JBJS Reviews for indexing in MEDLINE/PubMed.
Launched in November 2013 and edited by Thomas A. Einhorn, MD and a distinguished editorial board, JBJS Reviews is an innovative, continuously published online review journal from the publishers of The Journal of Bone & Joint Surgery.
Each weekly posting of JBJS Reviews content updates the orthopaedic community on important topics in a concise, time-saving manner. Comprehensive reviews, special features, and integrated CME provide musculoskeletal clinicians with valuable perspectives on surgical practice and the latest advances in the field within twelve subspecialty areas.
If you are not already a JBJS Reviews subscriber, click here to learn more.
The Editors of The Journal of Bone & Joint Surgery are pleased to announce the launch of JBJS Open Access. This new online-only journal gives authors an open-access option bolstered by the outstanding service and brand of excellence that JBJS has delivered for more than 125 years. And readers worldwide will benefit from expanded access to the best clinical and basic-science content about musculoskeletal health and injury care.
JBJS Open Access Co-editors Dr. Eng Lee and Dr. Robin Richards are not only expert basic-science and clinical researchers, but together they have more than 60 years of experience in scholarly publishing.
Click here for more information about this latest step in our continuing effort to meet the evolving needs of authors and readers.
Marc Swiontkowski, MD
For the second year in a row, The Journal of Bone & Joint Surgery (JBJS) has topped the field of orthopaedic journals in Impact Factor (IF). The Impact Factor measures the citation performance of a journal over a two-year period.
According to data from the 2015 edition of Journal Citation Reports (JCR), the JBJS Impact Factor is 5.163—the only orthopaedic journal to have an IF above 5.0. JBJS articles were cited a total of 3,268 times during 2013 and 2014, a 10.5% increase relative to the prior two-year period. In addition, The Journal’s five-year Impact Factor, an even more robust representation of sustained impact, was 5.372.
Although the Impact Factor is just one metric by which The Journal’s influence on musculoskeletal care is measured, our highest-in-the-field number is a testament to the ceaselessly hard working editors, reviewers, and authors who are responsible for the practice-changing content we publish.
For those of you interested in revisiting the most influential work in orthopaedics, according to JCR data, here are the top-three cited JBJS articles published in 2013-2014:
- Estimating the Burden of Total Knee Replacement in the United States
- Impact of the Economic Downturn on Total Joint Replacement Demand in the United States
- Risk Factors Associated with Deep Surgical Site Infections After Primary Total Knee Arthroplasty
Jason Miller, JBJS Executive Publisher
Three years ago today, the 2013 Boston Marathon was stolen from the athletes and the city by two terrorist bombs, which led to four deaths and hundreds of injuries. In March 2014, in conjunction with our friends at the Journal of Orthopaedic and Sports Physical Therapy (JOSPT), JBJS published It Takes a Team, a special report on the emergency preparedness, long-term care, and outcomes for many of those caught up in the Marathon bombings. This report is available online for free.
Not a single bombing victim who reached a hospital alive on April 15, 2013 died, a stunning result of years of preparation and teamwork. It Takes a Team provides a behind-the-scenes look at how the level 1 trauma centers involved that day ensured that their staffs had the emotional backing, resources, and systems in place so they could focus on their seriously injured patients.
As runners and spectators prepare for the 2016 Boston Marathon, we remember those we lost, those who survived, and the countless number of people who are helping those affected face the future with hope and dignity. We also thank the many people whose dedication to disaster-preparedness helps ensure that the 2016 and forthcoming Boston Marathons will go on.
Executive Publisher, JBJS
Last week, Thomson Reuters released the 2014 edition of the Journal Citation Reports (JCR). This annual report includes several journal performance metrics, the best known of which is certainly the Impact Factor. The Impact Factor measures the citation performance of journal articles over a two-year period.
Like all metrics, the Impact Factor has its strengths and weaknesses, its champions and detractors. At JBJS, we are focused on a range of metrics, including the quality of articles submitted to us for publication, author satisfaction, and direct reader feedback and engagement.
Having said that, we wish to acknowledge the painstaking work by our Editor-in-Chief, Editorial Board, reviewers, and authors who contributed to a second straight year of dramatic growth in our Impact Factor, which increased 22.5% to 5.280 (from 4.309). That’s the highest Impact Factor among the 72 orthopaedic journals included in the JCR.
We’re proud that JBJS is having a steadily increasing influence as a source of orthopaedic information. Our ultimate goal remains the same, however – to have a positive impact on surgical expertise, clinical outcomes, and patient care.
–Mady Tissenbaum, Publisher, JBJS
A year ago we debuted the “peer-review statement” in The Journal to emphasize our commitment to pre-publication peer review and to the rigorous, double-blind peer-review process that is integral to our editorial standards.
Today we are happy to announce our participation in PRE-val, the flagship service offered by PRE (Peer Review Evaluation). Our readers will notice the PRE-val badge above the article title for most JBJS articles published on our website in the past 12 months. Clicking on the badge reveals the PRE-val window, which provides detail about the peer review for that particular article. We know that your confidence in the reliability of the information published in The Journal will be increased by the enhanced transparency of our peer-review process.
As a result of the commitment to peer review shared by JBJS and PRE, our Board of Trustees approved the acquisition of PRE in 2014. We are excited about this launch, and we look forward to the implementation of this valuable service on the sites of our partner publishers over the coming months. You can learn more about PRE here. Of course, we welcome your feedback; please let us know what you think of this initiative by writing to us at email@example.com.
Medical publishing continues to evolve-sometimes to keep up with technology, sometimes due to financial constraints, and, unfortunately, sometimes in ways that make some of us uncomfortable-but readers of JBJS can be assured that our commitment to peer review and the quality it helps us to achieve will not waver. “Excellence Through Peer Review” will always remain a critical element of our core mission.
–Mady Tissenbaum, Publisher, JBJS
One measure of success for leaders is whether the organization they’ve led is stronger upon their departure. That’s a responsibility I’ve taken seriously for nearly 5 years as CEO/Publisher of STRIATUS/JBJS, Inc.
In the near future, I will be leaving STRIATUS/JBJS, Inc. to become Publisher at the American Association for the Advancement of Science (AAAS), which publishes the journal Science, along with Science: Translational Medicine, Science: Signaling, and Science: Advances.
While I’m sad to leave my colleagues and this audience, I’m happy to report that over the last 5 years, STRIATUS/JBJS, Inc. has improved and grown in a number of ways:
- This year, The Journal’s impact factor increased nearly 33% to its highest level ever, while The Journal remains the most-read journal in the specialty.
- Our new review journal, JBJS Reviews, is already one of the top online journal destinations in the field.
- The new JBJS Recertification Course has proven popular and effective with surgeons preparing for their maintenance-of-certification exams.
- JBJS Case Connector is improving clinical awareness and acumen on a monthly basis, with “Case Connections” synthesizing old and new information and “Watches & Warnings” alerting the field to emerging trends.
- With a growing video library, JBJS Essential Surgical Techniques continues to provide in-depth, step-by-step guidance on new surgical techniques, and plans to take practical surgical video to a new level in 2015.
With an excellent editorial team led by our new Editor-in-Chief, Marc Swiontkowski, MD, these journal and educational products are poised for long-term success.
In addition to improving and extending its core products, STRIATUS/JBJS, Inc., has diversified into new areas, adding important tools to the scientific literature, products emphasizing quality evidence and peer review. SocialCite, which allows feedback on the quality and appropriateness of journal citations, has major publishers participating in its pilot phase. PRE-val, which brings increased transparency and accountability to peer review, is also generating significant interest across the sciences.
It has been an honor working with the superb staff and editors at STRIATUS/JBJS, Inc., as well as serving the orthopaedic community – orthopaedic surgeons, physical therapists, physician assistants, and others – over the last 5 years. Thank you.
The Impact Factor uses a simple calculation – number of citations to scholarly articles published in a two-year period divided by the number of those articles. The resulting number allows various constituencies to compare the purported intellectual impact of a particular journal against other comparable journals and to trend impact over time.
For years, The Journal of Bone & Joint Surgery has focused on giving surgeons at the interface of clinical practice and academic research the best information possible, making the Impact Factor a number we didn’t focus on much. Our measurements of reader feedback and engagement have been much more important, and will continue to be.
Still, imagine our pleasant surprise when this year our Impact Factor rose dramatically, increasing 33% from 3.234 to 4.309. In addition, measurements such as what Thomson Reuters calls the “Article Influence Score” roughly doubled for JBJS.
There are many reasons for increases like this, but excellent editorial content is clearly the leading candidate for praise. As you know, Vern Tolo, MD, recently transitioned out of the role of Editor-in-Chief for The Journal. He clearly deserves much of the credit for these numbers, which occurred under his careful editorial stewardship. The Journal’s superb Deputy Editors, methodology and statistical consultants, and editorial staff also deserve praise for consistently pushing the standards of The Journal higher.
Best of all, our Impact Factor rose while our engagement with readers also increased. Recent readership surveys show that our readers are reading us in print as much as ever, online more than ever, and engaging with our social media outlets more and more every day..
We’re proud that JBJS has increasing impact as an orthoapedic journal. Our goal remains the same, however – to have a positive impact on surgical expertise, patient care, and outcomes.
Journals provide third-party validation for research reports. If you get published in a better journal, your work will likely be perceived as having been more successful. Editors and publishers feel the same way when it comes to how our audience rates our products. So we were very pleased when a recent independent third-party study found that our new review journal, JBJS Reviews, has rapidly become the #3 online journal in orthopaedics.
JBJS Reviews was launched just over six months ago, but it is already viewed as one of the top 3 professional resources for quality content, helping run an orthopaedic practice, and keeping surgeons informed. There are many other categories, but you get the idea – JBJS Reviews is already proving its worth.
Our Editor-in-Chief for JBJS Reviews, Tom Einhorn, MD, has done a fabulous job getting this new journal off the ground, and dozens of authors have contributed excellent reviews, and more are scheduled. We’re excited about the potential here.
That being said, the Journal of Bone & Joint Surgery still ranks #1 in nearly every category, so we have a lot to build upon there, as well. And that’s how we view it – being #1 is not a destination but an expectation, as is quickly joining the top 3. We need to keep working at a high level, improving what we do, and delivering great information in all formats.
Earlier this year, the Journal introduced the Peer-Review Statement, granting readers insight into how articles are peer-reviewed. A high percentage of readers find this valuable, we’ve learned. We are also introducing an integrated tablet app for iOS and Android devices. All our journals – the Journal, JBJS Reviews, JBJS Case Connector, and JBJS Essential Surgical Techniques – will appear in the single app. Best of all, if you already use the JBJS Reviews app, your next update will give you the integrated app seamlessly.
We value our readers and know how important your work is and how valuable your time is. I hope these improvements and high-quality resources serve you well.